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The pentachloro- and pentafluorophenyl esters, of /-butyloxycarbonyl (BOC)-l-14C-glycine*, 
were prepared, and hence the l-14C-glycine-labelled C-terminal pentapeptide of gastrin. Three 
pentapeptides of different specific radioactivities were prepared for a study of in vivo metabolism ' 
and transport phenomena. 
. The C-terminal tetrapeptide of gastrin (H-Trp-Met-Asp-PheNH2) is known 
to exhibit the full range of biological activity of the original heptadecapeptide [1]. 
Numerous analogues of this tetrapeptide have been synthesized to study the con-
nections between chemical structure and biological activity [2]. We wished to study 
the mechanism of action, transport and metabolism of gastrin and its C-terminal 
pentapeptide. Therefore, the pentapeptide BOC-l-14C-Gly-Trp-Met-Asp-PheNH2 
was synthesized, first with two different low specific radioactivities (168 ^Ci/mmole 
and 450 (iCi/mmole), and used them in a study of the metabolism [3]. Later, a 
pentapeptide of higher specific activity (7.5 mCi/mmole), necessary for autoradiographie 
investigations with light- and electronmicroscopy, was synthesized. 
l-14C-glycine was prepared from l-14C-bromoacetic acid of three different specific 
radioactivities by the method described by MURRAY and. WILLIAM [4]. We tried to 
elaborate a method which permits application of radioactive glycine with the highest 
efficiency possible. To this end the pentapeptide .was synthesized by two different: 
methods. 
The tetrapeptide used in. the synthesis of both pentapeptides of lower specific 
radioactivity was prepared by applying pentachlorophenyl esters of BOC-amino-
acids, and by protecting the /?-carboxyl group of the aspartic acid with a i-butyl 
group (Fig. 1). The yield of the coupling of active, esters was 80—85% in each case. 
Coupling of BOC-l-14C-glycine was also achieved via the pentachlorophenyl ester,. 
* Abbreviations accepted by the IUPAC-IUB (1967) for peptide chemistry are used in this, 
paper: Z = carbobenzyloxy = benzyloxycarbonyl; BOC = /-butyloxycarbonyl; FOR = formyl;. 
OBut = i-butylester. t 
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with an 85% yield in this case, too. The pentapeptides proved not quite homogeneous; 
further purification was necessary, presumably because of partial oxidation of the 
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Fig. 1 • 
In the synthesis of the radioactive pentapeptide of higher specific activity, use 
was made of the experience obtained in the above syntheses. The tetrapeptide was 
prepared by the method of KISFALUDY et al. [5]. Application of the pentafluorophenyl 
esters of BOC amino acids in a twofold excess resulted in very rapid synthesis. The 
j?-carboxyl group of the aspartic acid was protected with a /-butyl group in this 
case, too; the indole ring of the tryptophan was protected with a formyl group [6] 
to avoid side-reactions (Fig. 1). The yields of the coupling steps were about 90%, 
and we succeeded in obtaining the pure tetrapeptide H-Trp-Met-Asp-PheNH2. The 
pentafluorophenyl ester of BOC-l:14C-glycine was prepared in 97% yield, and 
coupled with the equivalent quantity of the above tetrapeptide. Splitting-off of the 
Nim-formyl group from the pentapeptide gave an 85% yield of radiochromato-
graphically-pure pentapeptide (checked in 3 different solvent systems). The purity 
was also checked by amino acid analysis. 
Comparison of the two methods of synthesis indicated the use of pentafluoro-
phenyl esters to be the more favourable. 
All three radioactive pentapeptides prepared proved to possess the full biological 
activity of the product ICI 50, 123 ("Peptavlon"). The measuring of biological 
activities was performed by conductometric titration of chloride ion liberated in rat 
stomach on the iv. dosage of pentapeptides. 
These preparations were mainly used to study the metabolism of the penta-
peptide [3, 7]. We recently started an investigation of the transport and the mechanism 
of action of the gastrin pentapeptide of higher activity. 
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Experimental 
Pentachlorophenyl ester of t-butyloxycarbonyl-l-uC-glycine 
1.17 g (4.4 mmole) pentachlorophenpl, dissolved in 15 ml ethyl acetate, was 
cooled to 0 °C, and 0.824 g (4.0 mmole) dicyclohexylcarbodiimide (DCC), dissolved 
in 2 ml ethyl acetate, was added. After 2 min stirring, 0.700 g (4.0 mmole) BOC-1-
14C-glycine, dissolved in 4 ml ethyl acetate, was added to the solution, which was 
subsequently stirred at 0 °C for 1 hr and left to stand overnight. The dicyclohexylurea 
(DCU) formed was filtered off, the solution was evaporated to dryness, and the 
residue was dissolved in tetrahydrofuran which was next cooled to 0 °C. After the 
precipitated DCU had been filtered off, the solution was evaporated to dryness and 
the active ester crystallized from ethyl acetate—petroleum ether. Yield: 1.43 g (85%) 
chromatographically-pure product; m.p.: 138—139 °C (lit. 142°C [8]). The specific 
radioactivities of two preparates worked up with these quantities were 168 jiCi/mmole 
and 450 nCi/mmole, respectively; these data are equal to those for the original 
BOG-1 -14C-glycine materials. 
Pentafluorophenyl ester of t-butyloxycarbonyl-l-uC-glycine 
17.5 mg (0.1 mmole) BOC-l-14C-glycine and 22 mg (0.12 mmole) pentafluoro-
phenol, dissolved in 0.2 ml ethyl acetate, was cooled to 0°C, 25 mg (0.12 mmole) 
DCC dissolved in 0.1 ml ethyl acetate was added, and the mixture was stirred at 
0 °C for 1 hr and then left to stand at - 1 0 °C for 30 min. After the DCU had been 
filtered off, the solution was evaporated to dryness and the crude product was 
triturated with n-hexane. Yield: 32 mg (95%) chromatographically-pure product; 
m.p.: 75—76°C (lit. 79—80°C [9]). Specific radioactivity: 7.5 mCi/mmole; this 
is equal to the value for the original BOC-l-14C-glycine. 
Tryptophyl-methionyl-asparaginyl-phenylalanineamide 
Method (a) (with pentachlorophenyl esters). Starting from 3.28 g (20 mmole) 
phenylalanineamide, equivalent quantities of pentachlorophenyl esters of carbo-
benzyloxy or BOC amino acids were used in each step of the synthesis. Coupling 
was performed in DMF; after 24 hr reaction time the mixture was poured into 
0.2 M aqueous KHS04 and ether with vigorous stirring at 0°C. The protected 
peptides, which solidified after a short standing, were filtered and purified by 
crystallization. The data obtained for the different. protected peptides were as 
follows: Z-Asp(OBut)-PheNH2 7.05g (15mmole, 75%), m.p.: 158°C, recrystallized 
from isopropanol ; BOC-Met-Asp-PheNH2 6.3g (12.5mmole, 83 %), m.p. : 208—209°C, " 
crystallized from 2-ethoxy-ethanol; BOC-Trp-Met-Asp-PheNH2 6.95 g (10 mmole, 
80%), m.p.: 212—213 °C. The carbobenzyloxy protecting group was split off by 
hydrogénation, and the other protecting groups (BOC- and OBut) by acidolysis with 
90% trifluoroacetic acid (TFA) for 30 min; in the case of the tripeptide and tetra-
peptide, a N2-blanket was used and 5 % thioglycolic acid was added to the mixture 
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in order to avoid oxidation. The tetrapeptide trifluoracetate was crystallized from 
methanol—ether, m.p.: 192—194°C; m.p. of the free base: 245—248 °C 
Method (b) (with pentafluorophenyl esters). In this synthesis we started from 
2 mmole phenylalanineamide, used in a twofold excess, in this case with respect 
to the Z-Asp(OBut)-OPFP. In the further coupling steps, the corresponding BOC 
amino acid pentafluorophenyl esters were applied in twofold excess. The couplings 
were performed in DMF, the pH being adjusted to about 8—8.5 by addition of tri-
ethylamine. After 30—60 min reaction time the DMF was evaporated off and the 
residue was dissolved in ethyl acetate, washed with 0.5 M aqueous KHS04 , then 
with water, dried and evaporated. The protected peptides were crystallized from 
mixtures of ethyl acetate—hexane or ether—hexane, in which the starting penta-
fluorophenyl esters remained dissolved. The protected tetrapeptide was isolated by 
pouring into a mixture of 0.2 M aqueous KHS04 and ether. The results obtained 
for the different protected peptides were as follows: Z-Asp(OBut)-PheNH2 0.42 g 
(0.9 mmole, 90%), m.p.: 156—158°C; BOC-Met-Asp-(OBut)-PheNH2 0.40 g 
(0.76mmole, 85%), m.p.: 172—173°C; BOC-Trp-(FOR)-Met-Asp-PheNH3 0.47 g 
(0.66 mmole, 87%), m.p. : 209—210 °C. The carbobenzyloxy protecting group -was 
split off by hydrogénation, and the BOC- and -OBut protecting groups with 4NHC1 
in dioxan for 30 min; in the case of the tripeptide and tetrapeptide a N2-blanket 
was used and 5% thioglycolic acid was added to the mixture in order to avoid 
oxidation. The free tetrapeptide hydrochloride was obtained in 97% yield; m.p.: 
220—222 °C. 
t-Butyloxycarbonyl-l-uC-glycyl-tryptophyl-methionyl-asparaginyl-phenylalanineamide 
Method (a) (with pentachlorophenyl ester). 2.04 g (3.4 mmole) tetrapeptide 
synthesized by method (a) and 1.43 g (3.4 mmole) BOC-l-14C-glycine-pentachloro-
phenyl ester were dissolved in 15 ml DMF, and 0.77 ml (7 mmole) N-methylihorpho-
line was added. After 36 hr reaction time, the mixture was poured into a mixture of 
100 ml 0.2 M 
aqueous KHS04 and 30 ml ether under vigorous stirring at 0 °C. 
After 30 min stirring the protected pentapeptide was filtered off, washed with water, 
then with ether, and dried in an exsiccator. The crude product (2.1 g, 85%) was 
purified by chromatography on a silica gel-column and eluted with a 60:20:6:11 
mixture of ethyl acetate—pyridine—acetic acid—water. Yield: 1.8 g (70%) radio-
chromatographically homogeneous product, Rf values: 0.42 (chloroform—metha-
nol—acetic acid 70:30:1); 0.58 (n-butanol—water—acetic acid 4:1:1); 0.31 (ethyl 
acetate—pyridine—water—acetic acid 120:20:: 11:6). M.p.: 197—200°C. [a]f,2 = 
= —29±2° (c= 1.0, DMF). Amino acid analysis: Phe 1.00; Asp 0.95; Met 0.93; 
Gly 1.02; Trp 0.90. 
Anal.: C36H4709N,S (753.8). Calc.: C 57.4, H 6.25, N 12.9%. Found: C 57.1, 
H 6.30, N 13.2%. 
Method (b) (with pentafluorophenyl ester). 59 mg (0.095 mmole) H-Trp(FOR> 
-Met-Asp-PheNH2 and 32 mg (0.095 mmole) BOC-l-14C-Gly-OPFP were dissolved 
in 0.5 ml DMF, and 0.022 ml (0.2 mmole) N-methylmorpholine was added. During 
the reaction the pH was held constant at pH 8 by addition of N-methylmorpholine; 
the reaction was quantitatively complete in 6 hr. The reaction mixture was poured 
into a mixture of 5 ml 0.2 M aqueous KHS04 and 2 ml ether under vigorous stirring. 
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The protected pentapeptide was filtered off, washed with water, ether, and «-hexane 
and dried. In order to split off the Nim-formyl group, the protected pentapeptide 
was dissolved in 0.5 ml DMF, and 5 equivalents of piperidine were added [10]; 
after 0.5 hr the pentapeptide was poured into a mixture of 0.2 M aqueous KHS04 
and ether, as described above. 60.3 mg (0.08 mmole, 85 %) radiochromatographically-
pure pentapeptide was obtained, Rvalues: 0.40 (chloroform—methanol—-acetic 
acid 70:30:1); 0.56 (n-butanol—water—acetic acid 120:20:11:6). M.p.: 204— 
205°C, specific activity: 7.5 mCi/mmoIe. Amino acid analysis: Gly 1.00; Phe 
1.04; Asp 0.95; Met 0.92; Trp 0.92. 
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CHHTÉ3 С-КОНЦЕВОГО ПЕНТАПЕПТИДА ГАСГРИНА, 
СОДЕРЖАЩЕГО 1-"С-ГЛИЦИНА 
'Л. Балашпири, Б. Пэнкэ, П. Паллаи, Ф. Широкман, Л. Варга и В.Варро 
Синтезированы пентафлор- и пентафторфениловый эфир трёт-бутилоксикарбонил-1-
-14С-глицина, и с применением этих эфиров С-концевого пентапептида гастрина, содержа-
щего 1-14С-глицина. Синтезированы 3 разных специфических радиоактивных пентапептида, 
для ,,in vivo" исследования-метаболических и транспортных процессов. 
